HMGCS2 functions as a tumor suppressor and has a prognostic impact in prostate cancer
ConclusionsOur data indicate that HMGCS2 may be capable of predicting the risk of biochemical recurrence in PCa patients after radical prostatectomy and functions as a tumor suppressor in PCa cancer, implying its related pathway potential as a drug candidate in anti-PCa therapy.
Source: Pathology Research and Practice - Category: Pathology Source Type: research
More News: Cancer | Cancer & Oncology | Pathology | Prostate Cancer | Prostatectomy | Statistics | Study